{"version":"1.0","type":"link","title":"The race between 4-1BB- and CD28-based CD19 CAR-T products in the therapy of B-cell malignancies.","author_name":"Krawczyk M 외","author_url":"https://prs-insight.online/author/Krawczyk%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/85026","thumbnail_width":1200,"thumbnail_height":630}